logo

Pdl Biopharma Inc. (PDLI)



Trade PDLI now with
  Date
  Headline
3/8/2018 4:04:13 PM PDL BioPharma Q4 GAAP EPS $0.15 Vs Loss $0.06 Prior Year
2/26/2018 11:23:50 AM LENSAR Appoints Richard Lindstrom To Board Of Directors
2/20/2018 10:04:24 AM Neos Therapeutics Reiterates Confidence In Strategic Plan And Value Creation Opportunities
2/20/2018 7:03:33 AM PDL BioPharma To No Longer Pursue Its Proposed Acquisition Of Neos Therapeutics
9/25/2017 7:04:42 AM PDL BioPharma Inc. (PDLI) Announces $25 Mln Stock Repurchase Plan
3/1/2017 7:02:40 AM PDL BioPharma Inc. (PDLI) Announces $30 Mln Stock Repurchase Plan
11/4/2016 9:39:37 AM RBC Capital Markets Is Cutting PDL BioPharma Inc. (PDLI) 2018 Rev. Estimate To 201.5 M From 201.7 M
11/4/2016 9:39:20 AM RBC Capital Markets Is Cutting PDL BioPharma Inc. (PDLI) 2017 Rev. Estimate To 199.7 M From 199.8 M
11/4/2016 9:38:48 AM RBC Capital Markets Is Increasing PDL BioPharma Inc. (PDLI) 2016 Rev. Estimate To 239.4 M From 207.0 M
11/4/2016 9:37:30 AM RBC Capital Markets Is Lowering PDL BioPharma Inc. (PDLI) 2018 Estimate To 0.28 From 0.29
11/4/2016 9:37:20 AM RBC Capital Markets Is Cutting PDL BioPharma Inc. (PDLI) 2017 Estimate To 0.21 From 0.23
11/4/2016 9:37:07 AM RBC Capital Markets Is Raising PDL BioPharma Inc. (PDLI) 2016 Estimate To 0.54 From 0.36
5/5/2016 9:56:12 AM RBC Capital Markets Is Cutting PDL BioPharma Inc. (PDLI) 2017 Rev. Estimate To 62.0 M From 63.6 M
5/5/2016 9:55:53 AM RBC Capital Markets Is Lowering PDL BioPharma Inc. (PDLI) 2016 Rev. Estimate To 166.9 M From 219.6 M
5/5/2016 9:55:14 AM RBC Capital Markets Is Lowering PDL BioPharma Inc. (PDLI) Q4 16 Estimate To 0.02 From 0.05
5/5/2016 9:55:06 AM RBC Capital Markets Is Cutting PDL BioPharma Inc. (PDLI) Q3 16 Estimate To 0.02 From 0.05
5/5/2016 9:54:56 AM RBC Capital Markets Is Cutting PDL BioPharma Inc. (PDLI) Q2 16 Estimate To 0.06 From 0.09